A miracle ‘cure’ for a deadly spinal disorder is being rolled out on the NHS amid growing calls for the Government to urgently approve checks for all babies at birth.
The pioneering gene therapy Zolgensma that costs £1.8million per treatment has today been approved by NICE for infants before symptoms begin and irreversible disability is caused.
However the UK’s newborn heel prick test still does not check for spinal muscular atrophy (SMA) which sees muscle weakness, loss of movement, difficulty breathing – and a life expectancy of just two years without treatment.
Read more at: https://www.mirror.co.uk/news/health/breaking-miracle-cure-spinal-disorder-29471959
